2. Search Result
Search Result
Results for "

cellular+proliferation

" in MedChemExpress (MCE) Product Catalog:

30

Inhibitors & Agonists

2

Peptides

3

Natural
Products

14

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N0650
    L-Serine
    10+ Cited Publications

    Serine

    		 Endogenous Metabolite Bacterial Cancer
    L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine
  • HY-13001
    Quizartinib
    Maximum Cited Publications
    45 Publications Verification

    AC220

    		 FLT3 Apoptosis PDGFR c-Kit Cancer
    Quizartinib (AC220) is an orally active, potent and selective FLT3 inhibitor. Quizartinib inhibits kinase activity of mutant-FLT3, -PDGFRA and -KIT isoforms and inhibits autophosphorylation. Quizartinib inhibits cellular proliferation, induces apoptosis in cancer cells. Quizartinib can be used for the research of cancer .
    Quizartinib
  • HY-135954A
    PDK4-IN-1 hydrochloride
    3 Publications Verification

    		 PDHK Apoptosis Metabolic Disease Inflammation/Immunology Cancer
    PDK4-IN-1 hydrochloride is an anthraquinone derivative and a potent and orally active pyruvate dehydrogenase kinase 4 (PDK4) inhibitor with an IC50 value of 84 nM. PDK4-IN-1 hydrochloride potently represses cellular transformation and cellular proliferation and induces apoptosis. PDK4-IN-1 hydrochloride has antidiabetic, anticancer and anti-allergic activity .
    PDK4-IN-1 hydrochloride
  • HY-135954
    PDK4-IN-1
    3 Publications Verification

    		 PDHK Apoptosis Metabolic Disease Inflammation/Immunology Cancer
    PDK4-IN-1 is an anthraquinone derivative and a potent and orally active pyruvate dehydrogenase kinase 4 (PDK4) inhibitor with an IC50 value of 84 nM. PDK4-IN-1 potently represses cellular transformation and cellular proliferation and induces apoptosis. PDK4-IN-1 has antidiabetic, anticancer and anti-allergic activity .
    PDK4-IN-1
  • HY-148771
    MTX-23
    1 Publications Verification

    PROTAC AR-V7 degrader-2

    		 PROTACs Androgen Receptor Apoptosis Cancer
    MTX-23 is an AR-based PROTAC. MTX-23 inhibits CaP cellular proliferation by degrading AR-V7 and AR-FL. MTX-23 induces apoptosis .
    MTX-23
  • HY-N0650S
    L-Serine-13C3
    1 Publications Verification

    (-)-Serine-13C3; (S)-Serine-13C3

    		 Endogenous Metabolite Cancer
    L-Serine- 13C3 is the 13C-labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-13C3
  • HY-N0650S11
    L-Serine-d7

    (-)-Serine-d7; (S)-Serine-d7

    		 Isotope-Labeled Compounds Endogenous Metabolite Cancer
    L-Serine-d7 is the deuterium labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-d7
  • HY-14217
    Quizartinib dihydrochloride
    Maximum Cited Publications
    45 Publications Verification

    AC220 dihydrochloride

    		 FLT3 Apoptosis PDGFR c-Kit Cancer
    Quizartinib (AC220) dihydrochloride is an orally active, potent and selective FLT3 inhibitor. Quizartinib dihydrochloride inhibits kinase activity of mutant-FLT3, -PDGFRA and -KIT isoforms and inhibits autophosphorylation. Quizartinib dihydrochloride inhibits cellular proliferation, induces apoptosis in cancer cells. Quizartinib dihydrochloride can be used for the research of cancer .
    Quizartinib dihydrochloride
  • HY-N0650S8
    L-Serine-d3
    2 Publications Verification

    (-)-Serine-d3; (S)-Serine-d3

    		 Endogenous Metabolite Cancer
    L-Serine-d3 is the deuterium labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-d3
  • HY-N0650R
    L-Serine (Standard)
    1 Publications Verification

    Serine (Standard)

    		 Reference Standards Endogenous Metabolite Bacterial Cancer
    L-Serine (Standard) is the analytical standard of L-Serine. This product is intended for research and analytical applications. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine (Standard)
  • HY-N0650S3
    L-Serine-13C3,15N,d3

    (-)-Serine-13C3,15N,d3; (S)-Serine-13C3,15N,d3

    		 Isotope-Labeled Compounds Endogenous Metabolite Cancer
    L-Serine- 13C3, 15N,d3 is the deuterium, 13C-, and 15-labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-13C3,15N,d3
  • HY-N0650S10
    L-Serine-15N

    (-)-Serine-15N; (S)-Serine-15N

    		 Endogenous Metabolite Cancer
    L-Serine- 15N is the 15N-labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-15N
  • HY-N0650S1
    L-Serine-13C

    (-)-Serine-13C; (S)-Serine-13C

    		 Endogenous Metabolite Cancer
    L-Serine- 13C is the 13C-labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-13C
  • HY-N0650S5
    L-Serine-13C3,15N

    (-)-Serine-13C3,15N; (S)-Serine-13C3,15N

    		 Endogenous Metabolite Cancer
    L-Serine- 13C3, 15N is the 13C- and 15N-labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-13C3,15N
  • HY-135312
    AZ'6421

    		Estrogen Receptor/ERR PROTACs Cancer
    AZ'6421 acts as Protcolysis Targeting Chimera (PROTAC) to selectively degrade estrogen receptor alpha. AZ'6421 has a potent anti-tumour effect to inhibit the uncontrolled cellular proliferation which arises from malignant disease. AZ'6421 can be used for the research of cancer such as breast cancer .
    AZ'6421
  • HY-N0650S7
    L-Serine-d2

    (-)-Serine-d2; (S)-Serine-d2

    		 Isotope-Labeled Compounds Endogenous Metabolite Cancer
    L-Serine-d2 is the deuterium labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-d2
  • HY-N0650S2
    L-Serine-1-13C

    (-)-Serine-1-13C; (S)-Serine-1-13C

    		 Endogenous Metabolite Cancer
    L-Serine-1- 13C is the 13C-labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-1-13C
  • HY-N0650S6
    L-Serine1-13C,15N

    (-)-Serine-13C,15N; (S)-Serine-13C,15N

    		 Isotope-Labeled Compounds Endogenous Metabolite Cancer
    L-Serine1- 13C, 15N is the 13C- and 15N-labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine1-13C,15N
  • HY-W783446A
    DACH-Pt-SO4

    DACH-sulph

    		 DNA/RNA Synthesis Cancer
    DACH-Pt-SO4 (DACH-sulph) is an anti-tumor agent. DACH-Pt-SO4 inhibits DNA function and cellular proliferation. DACH-Pt-SO4 reduces chloramphenicol acetyltransferase (CAT) expression in repair-deficient cells. DACH-Pt-SO4 can be used for the study of cancer .
    DACH-Pt-SO4
  • HY-13001R
    Quizartinib (Standard)

    AC220 (Standard)

    		 Reference Standards FLT3 Apoptosis PDGFR c-Kit Cancer
    Quizartinib (AC220) (Standard) is the analytical standard of Quizartinib (HY-13001). This product is intended for research and analytical applications. Quizartinib is an orally active, potent and selective FLT3 inhibitor. Quizartinib inhibits kinase activity of mutant-FLT3, -PDGFRA and -KIT isoforms and inhibits autophosphorylation. Quizartinib inhibits cellular proliferation, induces apoptosis in cancer cells. Quizartinib can be used for the research of cancer .
    Quizartinib (Standard)
  • HY-N0650S4
    L-Serine-2-13C

    (-)-Serine-2-13C; (S)-Serine-2-13C

    		 Isotope-Labeled Compounds Endogenous Metabolite Cancer
    L-Serine-2- 13C is the 13C-labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-2-13C
  • HY-N0650S9
    L-Serine-15N,d3

    (-)-Serine-15N,d3; (S)-Serine-15N,d3

    		 Isotope-Labeled Compounds Endogenous Metabolite Cancer
    L-Serine- 15N,d3 is the deuterium and 15N-labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.
    L-Serine-15N,d3
  • HY-N0650S12
    L-Serine-d3,15n

    		Bacterial Endogenous Metabolite Cancer
    L-Serine- 15N,d3 is the deuterium and 15N labeled L-Serine[1]. L-Serine ((-)-Serine;(S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation[2].
    L-Serine-d3,15n
  • HY-E70837
    JNK2 Recombinant Human Active Protein Kinase

    		JNK Cancer
    JNK2 is a neuronal-specific isoform of JNK. JNK2 deficiency leads to reduced c-Jun degradation, thereby augmenting c-Jun levels and cellular proliferation. JNK2 Recombinant Human Active Protein Kinase is a recombinant JNK2 protein that can be used to study JNK2-related functions .
    JNK2 Recombinant Human Active Protein Kinase
  • HY-13001S
    Quizartinib-d8

    AC220-d8

    		 Isotope-Labeled Compounds Apoptosis FLT3 PDGFR c-Kit Cancer
    Quizartinib (AC220)-d8 is deuterium labeled Quizartinib (HY-13001). Quizartinib is an orally active, potent and selective FLT3 inhibitor. Quizartinib inhibits kinase activity of mutant-FLT3, -PDGFRA and -KIT isoforms and inhibits autophosphorylation. Quizartinib inhibits cellular proliferation, induces apoptosis in cancer cells. Quizartinib can be used for the research of cancer .
    Quizartinib-d8
  • HY-P10105
    TCL1(10-24)

    		Akt Apoptosis Cancer
    TCL1(10-24) is a encompassing the betaA strand of human TCL1. TCL1(10-24) is a Akt inhibitor. TCL1(10-24) interacts with the Akt PH domain prevented phosphoinositide binding and hence inhibits membrane translocation and activation of Akt. TCL1(10-24) inhibits cellular proliferation and anti-apoptosis. TCL1(10-24) has tumor growth in vivo .
    TCL1(10-24)
  • HY-113041F
    Prostaglandin A2-biotin

    PGA2-biotin; Medullin-biotin

    		 Biochemical Assay Reagents Others
    Prostaglandin A2-biotin (PGA2-biotin) is a biotin-labeled Prostaglandin A2 (HY-113041). Prostaglandin A2-biotin retains the activity of inhibiting cellular proliferation. Prostaglandin A2-biotin is an effective tool for studying the interaction between Prostaglandin A2 and cellular proteins and exploring the mechanism of its inhibition of cellular proliferation .
    Prostaglandin A2-biotin
  • HY-P11643
    LVV-hemorphin-7

    		Angiotensin Receptor Aminopeptidase DNA/RNA Synthesis Neurological Disease
    LVV-hemorphin-7 is an Angiotensin IV receptor ligand and IRAP inhibitor (IC50s: 17.6 nM for sheep adrenal IRAP; 5.0 nM for sheep cerebellum IRAP). LVV-hemorphin-7 inhibits the catalytic activity of IRAP. LVV-hemorphin-7 stimulates DNA synthesis. LVV-hemorphin-7 elicits a number of physiological effects, including cellular proliferation and memory enhancement .
    LVV-hemorphin-7
  • HY-N19830
    Guavenoic acid

    		Reactive Oxygen Species (ROS) Apoptosis Cancer
    Guavenoic acid is a triterpenoid compound that can be isolated from fresh leaves of Psidium guajava. Guavenoic acid protects cells in cellular oxidative damage models, inhibits intracellular ROS production, and suppresses cell apoptosis. Guavenoic acid significantly enhances cellular proliferation, promotes insulin synthesis and secretion, and upregulates the messenger RNA expression of insulin gene, PDX-1 and MafA. Guavenoic acid can be used in the research of diseases such as pancreatic islet β-cell tumors .
    Guavenoic acid
  • HY-181965
    KRAS G12C-IN-78

    		Ras ERK p38 MAPK Cancer
    KRAS G12C-IN-78 is a selective SWII-binding KRASG12C dual inhibitor targeting both inactive and active states. KRAS G12C-IN-78 rapidly inhibits ERK1/2 phosphorylation, induces covalent adduct formation with endogenous KRASG12C, suppresses MAPK pathway gene expression, and inhibits cellular proliferation in KRASG12C mutant cells. KRAS G12C-IN-78 can be used for the research of KRASG12C mutant solid tumors, including pancreatic ductal adenocarcinoma and non-small cell lung cancer .
    KRAS G12C-IN-78

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: